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Abstract
Conventional use of the site-specific recombinase Cre is a powerful technology in mouse, but almost absent in other
vertebrate model organisms. In zebrafish, Cre-mediated recombination efficiency was previously very low. Here we show
that using transposon-mediated transgenesis, Cre is in fact highly efficient in this organism. Furthermore, temporal control
of recombination can be achieved by using the ligand-inducible CreER
T2. Site-specific recombination only occurs upon
administration of the drug tamoxifen (TAM) or its active metabolite, 4-hydroxy-tamoxifen (4-OHT). Cre-mediated
recombination is detectable already 4 or 2 hours after administration of TAM or 4-OHT, demonstrating fast recombination
kinetics. In addition, low doses of TAM allow mosaic labeling of single cells. Combined, our results show that conditional
Cre/lox will be a valuable tool for both, embryonic and adult zebrafish studies. Furthermore, single copy insertion
transgenesis of Cre/lox constructs suggest a strategy suitable also for other organisms.
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Introduction
Zebrafish (Danio rerio) is a widely used model organism for
vertebrate development and disease [1] due to its short generation
time, large number of offspring and optical clarity which allow
large-scale forward mutagenesis screens with relative ease [2,3].
Techniques for reverse genetic analysis are available in zebrafish
including morpholino-mediated gene knock-down [4], TILLING
[5] and targeted mutagenesis using zinc-finger nucleases [6,7]. A
complementary reverse genetic application is the temporal and
spatial controlled over-expression of genes using the Gal4-UAS [8]
and the mifepristone-inducible LexPR system [9]. However,
control of the gene of interest is conferred by the presence of a
transcriptional activator, Gal4FF and LexPR, respectively. Once
the transcriptional activator has vanished, expression of the gene
of interest is lost, impeding genetic fate mapping in zebrafish. In
mouse the most common method for genetic fate mapping is the
use of site-specific recombinases such as Cre and Flp [10,11]. Cre
promotes strand exchanges between two 34-bp loxP target sites
without any additional cofactors. Each loxP site consists of two 13-
bp repeats flanking an 8-bp asymmetric spacer sequence that
confers directionality. Head-to-head orientation causes inversion
of the DNA between the two sites, whereas head-to-tail orientation
results in the excision of the intervening DNA sequence, an
irreversible reaction due to the loss of the excised product. Based
on the observation that the localization of proteins can be
controlled by a ligand when fused to a ligand-binding domain of a
steroid hormone receptor, chimeric Cre recombinases were
developed [12]. This approach offers temporal control of Cre-
mediated recombination and allows targeting late aspects of a
dynamic or broad Cre expression. Currently, Cre fused to the
mutated human ligand-binding domain of the estrogen receptor
(CreER
T2) has the best properties for ligand sensitivity and
inducible recombination efficiency [13].
Previous attempts to establish the Cre/loxP system in zebrafish
showed its general functionality in this organism [14,15] but
recombination was very inefficient [16,17]. In one of these studies,
the recombination efficiency was evaluated in embryos at 24 hours
post fertilization (hpf); only 129 recombined cells per animal could
be detected although the recombined transgene was driven by the
broad b-actin promoter and high, ubiquitous levels of Cre were
provided during gastrulation [16]. Currently, the reason for the
recombination inefficiency is unknown, but the method by which
transgenic zebrafish were generated, might be crucial. Until
recently, the method of choice remained the injection of plasmid
DNA into the cytoplasm of one cell-stage embryos resulting in
concatemeric DNA integration of up to 2000 copies [18,19]. Copy
number can be significantly lowered by meganuclease-mediated
transgenesis [20], but unambiguous site-specific recombination
requires single copy insertions which can only be achieved by
pseudotyped retrovirus [21] or transposon-mediated transgenesis
[22].
Results
Here, we used the Tol2 transposon system to generate a red-to-
green reporter line for easy detection of Cre activity. In the
absence of Cre activity the reporter line expresses DsRed2 under
the control of the Xenopus Elongation Factor 1 alpha (EF1a) promoter,
but changes to EGFP after a successful recombination event
(Fig. 1a,b). When crossed to the Tg(hsp70:EGFP-Cre) [14] line
which carries conventional Cre fused to EGFP under the control
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Cre-mediated recombination in a sex-specific manner even at
permissive temperatures. If the Tg(hsp70:EGFP-Cre) allele is
maternally provided, double transgenic embryos at 24 hpf show
complete loss of DsRed2 and ubiquitous EGFP expression,
indicating recombination in all cells (Fig. 1c). In contrast, paternal
contribution of the Tg(hsp70:EGFP-Cre) allele retains the strong
DsRed2 signal but nevertheless leads to significant EGFP
expression in a mosaic fashion (Fig. 1d). However, following a
brief heat induction at mid-gastrulation stages that results in only
weak EGFP fluorescence derived from the Tg(hsp70:EGFP-Cre)
allele, the DsRed2 signal is reduced and strong ubiquitous EGFP
expression can be observed in double transgenic embryos
(Fig. 1e,f). Analysis by in situ hybridization shows absence of
DsRed2 transcripts in these embryos (data not shown). This
indicates that the observed fluorescent DsRed2 is maternally
provided as well as translated from transcripts made prior the
recombination event. Although native EGFP fluorescence could
Figure 1. Cre-mediated recombination in the red-to-green reporter line. (a) Scheme of the recombination event. In the absence of Cre the
EF1a promoter drives the expression of DsRed2 but changes to EGFP after successful Cre-mediated recombination. (b) Embryos of the red-to-green
reporter line show strong DsRed2 and no EGFP fluorescence. (c) Maternal contribution of the Tg(hsp70:EGFP-Cre) allele results in complete loss of
DsRed2 and ubiquitous EGFP expression in double transgenic embryos. (d) Paternal contribution of the Tg(hsp70:EGFP-Cre) allele leads to strong
DsRed2 and mosaic EGFP expression in double transgenic embryos. (e) Paternal contribution of the Tg(hsp70:EGFP-Cre) allele and brief heat induction
at mid-gastrulation stages results in reduced DsRed2 and strong ubiquitous EGFP expression in double transgenic embryos. (f) Embryos of the
Tg(hsp70:EGFP-Cre) line show only weak EGFP fluorescence after brief heat induction at mid-gastrulation stages. b–f Lateral views of live 24 hpf
embryos bearing different transgenes. Scale bar, 125 mm.
doi:10.1371/journal.pone.0004640.g001
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promoter in the Tg(hsp70:EGFP-Cre) line at permissive tempera-
tures which was already reported for the similar Tg(hsp70:Cre) line
[16,17]. When we crossed our red-to-green reporter line with
Tg(hsp70:Cre) the results corroborated our previous finding with
one exception. Less maternal contribution is observed and double
transgenic embryos always display a strong DsRed2 signal and
significant EGFP expression in a mosaic fashion at 24 hpf. Again,
brief heat induction at mid-gastrulation stages leads to reduced
DsRed2 and strong ubiquitous EGFP expression at 24 hpf (data
not shown) indicating successful recombination events in most or
all cells. Our data show that Cre is highly efficient in zebrafish as
the basal leakiness of the hsp70 promoter is already sufficient to
induce significant recombination. This is in contrast to previous
findings resulting in low recombination frequencies even in the
presence of high Cre expression levels [16,17]. In both studies,
effector lines were generated by plasmid injection, whereas we
used transposon-mediated transgenesis. In agreement with that,
we also observed no or only poor recombination with other stable
red-to-green reporter lines that we generated by plasmid injection
(data not shown). Consequently, the transgenesis approach might
be crucial as only single copy insertions allow unambiguous Cre-
mediated excision events.
Because the leakiness of the hsp70 promoter results in non-
conditional recombination, we turned towards using the tamoxifen-
inducible CreER
T2 recombinase (Fig. 2a). We generated transgenic
lines driving CreER
T2 under the control of the zebrafish pax2a
promoter [23] and established two lines that express CreER
T2
transcriptsonlyinasubsetofthereportedpatternpresumablydueto
positioneffects.InTg(pax2a:CreER
T2)
#19CreER
T2isexpressedinthe
prospective diencephalon of the developing forebrain whereas in
Tg(pax2a:CreER
T2)
#45itisexpressedinthefuturerhombomere3and
5 of the hindbrain anlage (Fig. 2b,d). When crossed to our red-to-
green reporter line, a strong EGFP signal is detected in the
diencephalon or in rhombomere 3 and 5 in double transgenic
embryos at 24 hpf (Fig. 2c,e). Recombination was very robust, with
EGFP recapitulating the entire CreER
T2-positive domain of all
double transgenic embryos. However, different intensities in the
EGFP signal indicate that Cre recombinase-mediated recombina-
tion does not happen at the same time in all the cells of the CreER
T2-
Figure 2. Ligand-dependent Cre-mediated recombination. (a) Scheme of the ligand-dependent recombination event in cells of the red-to-
green reporter line. The chimeric CreER
T2 recombinase is retained in the cytoplasm in the absence of the ligand. After administration of TAM which is
converted to the active ligand 4-OHT, CreER
T2 translocates to the nucleus, where it catalyzes the recombination event. (b) Expression of CreER
T2 in
the diencephalon of the Tg(pax2a:CreER
T2)
#19 line at early segmentation stages revealed by in situ hybridization. (c) EGFP expression in the
diencephalon of double transgenic embryos at 24 hpf bearing the red-to-green reporter and the Tg(pax2a:CreER
T2)
#19 alleles after TAM treatment at
mid-gastrulation stages. (d) Expression of CreER
T2 in rhombomere 3 and 5 of the Tg(pax2a:CreER
T2)
#45 line at early segmentation stages revealed by
in situ hybridization. (e) EGFP expression in rhombomere 3 and 5 of double transgenic embryos at 24 hpf bearing the red-to-green reporter and the
Tg(pax2a:CreER
T2)
#45 alleles after TAM treatment at mid-gastrulation stages. Abbreviations: f, forebrain; h, hindbrain; m, midbrain. Scale bar, 50 mm.
doi:10.1371/journal.pone.0004640.g002
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T2
activation by tamoxifen (TAM), which was applied at mid-
gastrulation stages. We never observe any EGFP expression in the
absence of TAM indicating that CreER
T2 is successfully retained in
the cytoplasm. Thus, only administration of the ligand results in the
translocationoftherecombinasetothenucleus,whereitcatalyzesthe
recombinationevent.However, high levelsof CreER
T2, supplied by
mRNAinjectionorthehsp70promoterinastabletransgenicline,can
lead to non-conditional recombination (data not shown), suggesting
that very high levels of CreER
T2 can overwhelm the cellular
machinery.
We next addressed the kinetics of CreER
T2-mediated recom-
bination in zebrafish embryos. In mouse, TAM is most commonly
used to induce recombination. However, the active metabolite that
binds to the mutated ligand-binding domain of the human
estrogen receptor is 4-hydroxy-tamoxifen (4-OHT). Hepatic
conversion of TAM to 4-OHT results in a 6–12 hour time delay
between administration of TAM and onset of recombination [24].
To determine the time delay in zebrafish embryos, we crossed our
red-to-green reporter line with homozygous Tg(pax2a:CreER
T2)
#19
carriers which render all DsRed2-positive embryos also positive for
the CreER
T2 driver. At the 12-somite stage when CreER
T2 is
expressed strongly in the diencephalon of the developing forebrain
(Fig. 3a) we applied DMSO, TAM or 4-OHT and fixed embryos
after 2, 4 and 6 hour intervals, respectively. The EGFP signal was
detected by immunofluorescence staining with an anti-GFP
antibody, as EGFP-fluorescence requires a further 90 min to 4 h
after protein synthesis until the mature chromophore is folded
Figure 3. Kinetics of ligand-dependent Cre-mediated recombination. (a) Expression of CreER
T2 in the Tg(pax2a:CreER
T2)
#19 line at the 12-
somite stage revealed by in situ hybridization. (b) Control embryos treated with DMSO never show any EGFP. (c) Immunofluorescence staining with
antibodies to EGFP is detectable 4 hours after application of TAM and expanded further after 6 hours. (d) Onset of EGFP expression by
immunofluorescence staining is detected after 2 hours and expanded further after 4 and 6 hours after application of 4-OHT. a–d Dorsal views of
double transgenic embryos at 12-, 16-, 20 and 24-somite stage (15, 17, 19 and 21 hpf). Abbreviations: f, forebrain; e, eye anlage; h, hours; m, midbrain.
Scale bar, 30 mm.
doi:10.1371/journal.pone.0004640.g003
Cre/lox in Zebrafish
PLoS ONE | www.plosone.org 4 February 2009 | Volume 4 | Issue 2 | e4640[25]. As mentioned above, embryos never showed any EGFP
signal without TAM treatment (Fig. 3b). However after admin-
istration of TAM, positive recombination was already detectable
after 4 hours whereas widespread EGFP expression could be
observed after 6 hours (Fig. 3c). Onset of recombination was even
faster in embryos treated with 4-OHT. EGFP-positive cells were
already visible after 2 hours and widespread EGFP expression was
detected after 4 and 6 hours (Fig. 3d). In comparison to the EGFP
signal detected by immunofluorescence staining, native EGFP
fluorescence was observed 6 and 4 hours after the administration
of TAM and 4-OHT, respectively (data not shown). In addition to
the faster kinetics of 4-OHT, we also observe that 4-OHT is more
potent since the effective concentration of 4-OHT with 0.5 mMi s
one magnitude lower than the concentration of TAM (5 mM).
Taken together, our results show that ligand-mediated recombi-
nation is not only feasible but also surprisingly fast in the
developing zebrafish embryo. Furthermore, as the ligand is simply
administered to the medium the recombination event can be
precisely timed depending on the experimental goal.
Although most experiments may aim at maximal recombina-
tion, graded levels or even single recombined cells might be
preferred for certain studies. In mouse it has been shown that the
rate of recombination can be controlled by the dose of the ligand
administered [24]. Because the ligand controls the translocation of
the recombinase to the nucleus, lower ligand concentrations result
in less available nuclear CreER
T2 protein. Consequently, the
probability of recombination between the target loxP sites
decreases. In order to test this hypothesis in zebrafish we crossed
our red-to-green reporter with the Tg(pax2a:CreER
T2)
#19 and
Tg(pax2a:CreER
T2)
#45 lines and exposed the progeny to different
TAM concentrations. TAM was applied at mid-gastrulation stages
and EGFP was detected by anti-GFP antibody staining in embryos
fixed at 24 hpf. Our toxicity analysis revealed aberrant
development and embryonic lethality with TAM concentrations
of 10 mM and higher (data not shown). Thus our experiments
were carried out with 5 mM TAM representing maximal
recombination in proper developing embryos. However, after
lowering TAM concentrations we observe different outcomes for
the Tg(pax2a:CreER
T2)
#19 and Tg(pax2a:CreER
T2)
#45 lines, respec-
tively. Double transgenic embryos carrying the reporter and the
Tg(pax2a:CreER
T2)
#19 allele show lower but still substantial EGFP
expression at 0.5 mM TAM and single recombined cells can be
observed at 0.05 mM TAM (Fig. 4a). In contrast, combination of
the Tg(pax2a:CreER
T2)
#45 allele with the reporter line results in
single recombined cells at a concentration of 0.5 mM TAM
(Fig. 4b). As our in situ analysis revealed higher CreER
T2
expression levels in the Tg(pax2a:CreER
T2)
#19 line than in the
Tg(pax2a:CreER
T2)
#45 line, we assume that the difference in
CreER
T2 expression levels is responsible for the observed rate of
recombination at lower TAM concentrations. Combined, our data
show that graded levels and even single recombination events can
be achieved. However, TAM conditions depend on the expression
strength of CreER
T2 and hence need to be tested and optimized
for each CreER
T2 driver line.
Discussion
In principle, the use of our red-to-green reporter line should
allow genetic fate mapping in zebrafish in the same manner as in
mouse. In mouse ubiquitous expression is most commonly
achieved by the use of the Rosa26 locus [26], whereas we use
the EF1a promoter which has been reported to show high and
ubiquitous expression in zebrafish [22]. However, although we see
strong ubiquitous expression on the protein level for up to 7 days,
our in situ analysis reveals strong ubiquitous expression only during
gastrulation and mid-somitogenesis stages (data not shown).
Subsequently, expression is shut down in a tissue-specific manner
with strong transcription maintained only in the retina and mid-
hindbrain boundary beyond 24 hpf (data not shown). Expression
analysis of the EF1a promoter in the adult brain also revealed
promoter activity in a non-ubiquitous fashion (data not shown).
Thus, the EF1a promoter can be a valuable tool for embryonic
studies but further promoters need to be tested for actual
ubiquitous expression in zebrafish matching the usefulness of the
mouse Rosa26 locus. However, reporter genes driven by existing,
tissue-specific promoters should already allow the labeling of
smaller or even single gene expression domains in zebrafish.
Our work demonstrates the efficient use of the conditional Cre/
lox system in zebrafish. It will allow temporal and spatial
overexpression studies and facilitate bona fide lineage tracing of
cell fates. In addition, it will provide the opportunity to develop
recombinase-mediated techniques for genomic manipulations.
These include the generation of conditional knockout alleles
which are currently unavailable in zebrafish. Targeted mutagen-
esis using zinc-finger nuclease involves a double-strand break that
is repaired by nonhomologous end-joining [6,7]. The direct
ligation of the two DNA strands frequently results in the loss or
gain of small amounts of DNA sequence. If an exogenous repair
template is also supplied, the induced double-strand break can be
repaired by homology-directed repair and sequence alterations
encoded in the repair template are incorporated into the genome
[27]. In this way loxP target sites could be introduced to flank a
gene of interest which would allow the temporally controlled
inactivation of the gene by Cre-mediated recombination.
Finally, our results suggest that the use of site-specific
recombinases may be applicable to many other organisms that
can be subjected to single-copy transposon-mediated transgenesis
[28] as a prerequisite for efficient, unambiguous Cre-mediated
excision.
Materials and Methods
Plasmid construction
To create the pTol EF1a loxP-DsRed2-loxP EGFP plasmid,
three elements (the EF1a promoter, the loxP-DsRed2-loxP
cassette and the EGFP gene) were PCR-amplified flanked by
unique restriction sites that allow easy substitution of one of the
three elements in the final vector. The following enzymes were
used: XhoI and FseI for the EF1a promoter, FseI and SmaI for the
loxP-DsRed2-loxP cassette and SmaI and AscI for the EGFP gene.
The products were sequentially subcloned into the XhoI/AscI site
of the pTol2000 [22] vector which results in the opposite
orientation of the Tol2 transcription. The pTol pax2a:CreER
T2
plasmid was generated in the same manner. The following
enzymes were used: SalI and FseI for the pax2a promoter [23] and
FseI and AscI for the CreER
T2 gene [12]. Again the products were
subcloned into the XhoI/AscI site of the pTol2000
22 vector as SalI
and XhoI produce compatible cohesive ends.
Zebrafish husbandry and germ line transformation
Zebrafish embryos were obtained by natural spawnings of adult
AB wild-type fish maintained at 28.5uC on a 14 hour light,
10 hour dark cycle and staged as described [29]. For germ line
transformation, plasmid DNA and transposase mRNA were
injected into fertilized eggs (F0), raised to adulthood and crossed
to AB wild-type fish as previously described [22]. For the red-to-
green reporter line, F1 embryos were examined under a
fluorescent microscope and positive embryos were raised. This
Cre/lox in Zebrafish
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recombination in the presence of Cre. As they all showed efficient
recombination, the strongest allele was chosen to establish the red-
to-green reporter line which now shows efficient recombination in
the third generation. For the pax2a:CreER
T2 line, F1 embryos were
screened by PCR using pax2a (ttgccaacgttgtaggctactacc)- and Cre
(tagagcctgttttgcacgttcacc)-specific primers that result in an 867
base pair fragment. Positive F0 were re-crossed, fixed at 24 hpf
and expression of CreER
T2 was analyzed by in situ hybridization.
Out of 8 PCR-positive F0 fish, only two lines,
Tg(pax2a:CreER
T2)
#19 and Tg(pax2a:CreER
T2)
#45 showed a distinc-
tive CreER
T2 expression pattern. Both lines were established and
carriers are identified by either PCR or cross to the red-to-green
reporter line.
Immunocytochemistry and in situ hybridization
Antibody staining was carried out as described [30]. Antibodies
were used in the following concentrations: a-GFP (Molecular
Probes), 1:500; goat a-rabbit Alexa Fluor 488 (Molecular Probes),
1:500. Embryos were analyzed using a Zeiss Axiophot 2
microscope. For probe synthesis the CreER
T2 gene was subcloned
into the CS2+ vector, linearized with BamHI and transcribed with
T7. Probe synthesis and in situ hybridization was performed
essentially as previously described [30].
Pharmacological treatments and brief heat induction
For pharmacological treatments the following stock solutions
were made and stored at 220uC: 50 mM tamoxifen (TAM;
Sigma, T5648) in DMSO; 25 mM 4-hydroxy-tamoxifen (4-OHT;
Sigma, H7904) in ethanol. For embryo treatments, dilutions of
these chemicals were made in embryo medium as follows: TAM:
5, 0.5 and 0.05 mM; 4-OHT: 0.5 mM. At mid-gastrulation (75%
epiboly or 8 hpf) or at 12-somite stage (15 hpf) embryos, still in
their chorions, were transferred into petri dishes containing the
treatment solution. For control treatments, sibling embryos were
incubated in corresponding dilutions of DMSO and ethanol. All
Figure 4. Dose-dependent recombination in the Tg(pax2a:CreER
T2)
#19 and Tg(pax2a:CreER
T2)
#45 lines by TAM. (a) Double transgenic
embryos bearing the red-to-green reporter and the Tg(pax2a:CreER
T2)
#19 alleles show strong EGFP expression in the diencephalon after application of
5 mM TAM at mid-gastrulation stages. Application of 0.5 mM TAM or 0.05 mM TAM at the same stage, results in reduced EGFP expression or single
EGFP-positive cells, respectively. (b) Double transgenic embryos bearing the red-to-green reporter and the Tg(pax2a:CreER
T2)
#45 alleles show strong
EGFP expression in rhombomere 3 and 5 after application of 5 mM TAM at mid-gastrulation stages. Application of 0.5 mM TAM at the same stage,
results in single EGFP-positive cells. a, b Dorsal views of double transgenic embryos at 24 hpf. Scale bar, 30 mm.
doi:10.1371/journal.pone.0004640.g004
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undechorionated embryos at mid-gastrulation stages were trans-
ferred into fresh petri dishes. After removal of excess embryo
medium, 42uC embryo medium was added and the petri dishes
were returned to the 28.5uC incubator. This heat induction
protocol results in only weak EGFP fluorescence at 24 hpf when
applied to the Tg(hsp70:EGFP-Cre) [16] line at mid-gastrulation
stages.
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